71 results on '"Siegel, Barry A."'
Search Results
2. rPOP: Robust PET-only processing of community acquired heterogeneous amyloid-PET data
3. Objective Task-Based Evaluation of Artificial Intelligence-Based Medical Imaging Methods: Framework, Strategies, and Role of the Physician
4. 18F-Fluciclovine Positron Emission Tomography in Men With Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy and Planning to Undergo Salvage Radiation Therapy: Results from LOCATE
5. FIGO 2018 staging criteria for cervical cancer: Impact on stage migration and survival
6. Intensity Modulated Radiation Therapy and Image-Guided Adapted Brachytherapy for Cervix Cancer
7. Evaluation of a Deep Learning-Based Transmission-Less Attenuation Correction Method for Myocardial Perfusion SPECT
8. Evaluation of a Computational Strategy To Personalize Myocardial Perfusion SPECT Acquisition Protocols Using Clinical Data From Female Patients With Large Breasts
9. Single-agent ibrutinib in relapsed or refractory follicular lymphoma: a phase 2 consortium trial
10. The Impact of Positron Emission Tomography with 18F-Fluciclovine on the Management of Patients with Biochemical Recurrence of Prostate Cancer: Results from the LOCATE Trial
11. Association of post-treatment positron emission tomography with locoregional control and survival after radiation therapy for squamous cell carcinoma of the vulva
12. [124I]FIAU: Human dosimetry and infection imaging in patients with suspected prosthetic joint infection
13. Regional Lymph Node Uptake of [18F]Fluorodeoxyglucose After Definitive Chemoradiation Therapy Predicts Local-Regional Failure of Locally Advanced Non-Small Cell Lung Cancer: Results of ACRIN 6668/RTOG 0235
14. Changes in Cervical Cancer FDG Uptake During Chemoradiation and Association With Response
15. Thyroid carcinoma uptake of 18 F-Fluorodeoxyglucose in patients with elevated serum thyroglobulin and negative 131I scintigraphy
16. FDG-PET-based prognostic nomograms for locally advanced cervical cancer
17. Geographic and Sociodemographic Disparities in PET Use by Medicare Beneficiaries With Cancer
18. Metabolic Response on Post-therapy FDG-PET Predicts Patterns of Failure After Radiotherapy for Cervical Cancer
19. Growth in the Use of PET for Six Cancer Types After Coverage by Medicare: Additive or Replacement?
20. A Phase II Comparative Study of Gross Tumor Volume Definition With or Without PET/CT Fusion in Dosimetric Planning for Non–Small-Cell Lung Cancer (NSCLC): Primary Analysis of Radiation Therapy Oncology Group (RTOG) 0515
21. Prognostic Utility of Squamous Cell Carcinoma Antigen in Carcinoma of the Cervix: Association With Pre- and Posttreatment FDG-PET
22. Clinical Outcomes of Definitive Intensity-Modulated Radiation Therapy With Fluorodeoxyglucose–Positron Emission Tomography Simulation in Patients With Locally Advanced Cervical Cancer
23. Anal cancer maximum F-18 fluorodeoxyglucose uptake on positron emission tomography is correlated with prognosis
24. Prognostic Value of Preoperative Positron Emission Tomography in Resected Stage I Non-small Cell Lung Cancer
25. A Prognostic System Applicable to Patients with Resectable Liver Metastasis from Colorectal Carcinoma Staged by Positron Emission Tomography with [ 18F]Fluoro-2-Deoxy-D-Glucose: Role of Primary Tumor Variables
26. FDG-PET Lymphoma Demonstration Project Invitational Workshop
27. Prognostic Value of Fluorodeoxyglucose Positron Emission Tomography in Non-small Cell Lung Cancer: A Review
28. Medicare Coverage of PET for Cervical Cancer
29. Concurrent PET/CT with an Integrated Imaging System: Intersociety Dialogue from the Joint Working Group of the American College of Radiology, the Society of Nuclear Medicine, and the Society of Computed Body Tomography and Magnetic Resonance
30. FDG-PET evaluation of vaginal carcinoma
31. Lack of benefit of concurrent chemotherapy in patients with cervical cancer and negative lymph nodes by FDG-PET
32. Lymph node control in cervical cancer
33. Impact of FDG-PET on radiation therapy volume delineation in non–small-cell lung cancer
34. Prospective evaluation of FDG-PET for detecting pelvic and para-aortic lymph node metastasis in uterine corpus cancer
35. Neoplasms of the esophagus and stomach
36. Assessing tumor hypoxia in cervical cancer by positron emission tomography with 60Cu-ATSM: Relationship to therapeutic response—a preliminary report
37. Posttherapy surveillance monitoring of cervical cancer by FDG-PET
38. FDG-PET lymph node staging and survival of patients with FIGO stage IIIb cervical carcinoma
39. Occult supraclavicular lymph node metastasis identified by FDG-PET in patients with carcinoma of the uterine cervix
40. Prospective Evaluation of Positron Emission Tomography for the Detection of Groin Node Metastases from Vulvar Cancer
41. FDG-PET Evaluation of Carcinoma of the Cervix
42. Early Assessment of Treatment Response in Acute Myeloid Leukemia Using FLT PET/CT Imaging: A Trial of the ECOG-ACRIN Cancer Research Group (EAI141)
43. RACIAL AND ETHNIC DIFFERENCES IN AMYLOID PET POSITIVITY IN THE IDEAS STUDY
44. PREDICTORS OF β-AMYLOID POSITIVITY IN COGNITIVELY IMPAIRED PATIENTS: DATA FROM THE IMAGING DEMENTIA – EVIDENCE FOR AMYLOID SCANNING (IDEAS) STUDY
45. PREDICTORS OF β-AMYLOID POSITIVITY IN COGNITIVELY IMPAIRED PATIENTS: DATA FROM THE IMAGING DEMENTIA — EVIDENCE FOR AMYLOID SCANNING (IDEAS) STUDY
46. IMPACT OF AMYLOID PET ON PATIENT MANAGEMENT: EARLY RESULTS FROM THE IDEAS STUDY
47. Performance Observations of Scanner Qualification of NCI-Designated Cancer Centers: Results From the Centers of Quantitative Imaging Excellence (CQIE) Program
48. chapter 6 - NUCLEAR IMAGING
49. 2038 11C-ACETATE PET/CT BEFORE RADICAL PROSTATECTOMY: NODAL STAGING AND TREATMENT FAILURE PREDICTION
50. 11C-ACETATE POSITRON EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY FOR PRE-OPERATIVE LYMPH NODE STAGING IN PROSTATE CANCER
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.